These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

536 related articles for article (PubMed ID: 29193840)

  • 1. Overweight, Obesity, and the Likelihood of Achieving Sustained Remission in Early Rheumatoid Arthritis: Results From a Multicenter Prospective Cohort Study.
    Schulman E; Bartlett SJ; Schieir O; Andersen KM; Boire G; Pope JE; Hitchon C; Jamal S; Thorne JC; Tin D; Keystone EC; Haraoui B; Goodman SM; Bykerk VP;
    Arthritis Care Res (Hoboken); 2018 Aug; 70(8):1185-1191. PubMed ID: 29193840
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overweight decreases the chance of achieving good response and low disease activity in early rheumatoid arthritis.
    Sandberg ME; Bengtsson C; Källberg H; Wesley A; Klareskog L; Alfredsson L; Saevarsdottir S
    Ann Rheum Dis; 2014 Nov; 73(11):2029-33. PubMed ID: 24818635
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Obesity is associated with a lower probability of achieving sustained minimal disease activity state among patients with psoriatic arthritis.
    Eder L; Thavaneswaran A; Chandran V; Cook RJ; Gladman DD
    Ann Rheum Dis; 2015 May; 74(5):813-7. PubMed ID: 24431392
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Body mass index and response to abatacept in rheumatoid arthritis.
    Gardette A; Ottaviani S; Sellam J; Berenbaum F; Lioté F; Fautrel B; Palazzo E; Meyer A; Sibilia J; Dieudé P
    Eur J Clin Invest; 2016 Dec; 46(12):1048-1052. PubMed ID: 27736006
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of body mass index on clinical response to abatacept as a first-line biologic for rheumatoid arthritis: 6-month results from the 2-year, observational, prospective ACTION study.
    Mariette X; Alten R; Nüßlein HG; Galeazzi M; Lorenz HM; Cantagrel A; Chartier M; Poncet C; Rauch C; Le Bars M
    Joint Bone Spine; 2017 Oct; 84(5):571-576. PubMed ID: 28043761
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Body mass does not impact the clinical response to intravenous abatacept in patients with rheumatoid arthritis. Analysis from the "pan-European registry collaboration for abatacept (PANABA).
    Iannone F; Courvoisier DS; Gottenberg JE; Hernandez MV; Lie E; Canhão H; Pavelka K; Hetland ML; Turesson C; Mariette X; Choquette D; Finckh A
    Clin Rheumatol; 2017 Apr; 36(4):773-779. PubMed ID: 27966068
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Body Mass Index Impact on Disease Activity, Clinical and Sonographic Remission Rates in Patients with Rheumatoid Arthritis.
    Sapundzhieva T; Karalilova R; Batalov A
    Curr Rheumatol Rev; 2019; 15(3):215-223. PubMed ID: 30499417
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Body mass index as a driver of selection of biologic therapy in rheumatoid arthritis. Results from the US-CLARA study.
    Di Carlo M; Salaffi F; Gremese E; Iannone F; Lapadula G; Ferraccioli G;
    Eur J Intern Med; 2019 Aug; 66():57-61. PubMed ID: 31113709
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Earlier time to remission predicts sustained clinical remission in early rheumatoid arthritis--results from the Canadian Early Arthritis Cohort (CATCH).
    Kuriya B; Xiong J; Boire G; Haraoui B; Hitchon C; Pope J; Thorne JC; Tin D; Keystone EC; Bykerk V;
    J Rheumatol; 2014 Nov; 41(11):2161-6. PubMed ID: 25274902
    [TBL] [Abstract][Full Text] [Related]  

  • 10. No predictive effect of body mass index on clinical response in patients with rheumatoid arthritis after 24 weeks of biological disease-modifying antirheumatic drugs: a single-center study.
    Kim SK; Choe JY; Park SH; Lee H
    Clin Rheumatol; 2016 May; 35(5):1129-36. PubMed ID: 26932795
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Are there differences between young- and older-onset early inflammatory arthritis and do these impact outcomes? An analysis from the CATCH cohort.
    Arnold MB; Bykerk VP; Boire G; Haraoui BP; Hitchon C; Thorne C; Keystone EC; Pope JE;
    Rheumatology (Oxford); 2014 Jun; 53(6):1075-86. PubMed ID: 24501240
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Body mass index and response to tocilizumab in rheumatoid arthritis: a real life study.
    Gardette A; Ottaviani S; Sellam J; Berenbaum F; Lioté F; Meyer A; Sibilia J; Fautrel B; Palazzo E; Dieudé P
    Clin Rheumatol; 2016 Apr; 35(4):857-61. PubMed ID: 26801332
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sustained Remission Improves Physical Function in Patients with Established Rheumatoid Arthritis, and Should Be a Treatment Goal: A Prospective Observational Cohort Study from Southern Sweden.
    Einarsson JT; Geborek P; Saxne T; Kristensen LE; Kapetanovic MC
    J Rheumatol; 2016 Jun; 43(6):1017-23. PubMed ID: 27036384
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the long-term outcome for patients with rheumatoid arthritis with persistent moderate disease activity or disease remission during the first year after diagnosis: data from the ESPOIR cohort.
    Combe B; Logeart I; Belkacemi MC; Dadoun S; Schaeverbeke T; Daurès JP; Dougados M
    Ann Rheum Dis; 2015 Apr; 74(4):724-9. PubMed ID: 24399234
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Body mass index and treatment survival in patients with RA starting treatment with TNFα-inhibitors: long-term follow-up in the real-life METEOR registry.
    Bergstra SA; Allaart CF; Vega-Morales D; De Buck M; Murphy E; Salomon Escoto K; Huizinga TWJ
    RMD Open; 2020 Jun; 6(2):. PubMed ID: 32506054
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disease-modifying antirheumatic drug-free sustained remission in rheumatoid arthritis: an increasingly achievable outcome with subsidence of disease symptoms.
    Ajeganova S; van Steenbergen HW; van Nies JA; Burgers LE; Huizinga TW; van der Helm-van Mil AH
    Ann Rheum Dis; 2016 May; 75(5):867-73. PubMed ID: 25972519
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sustained clinical remission of rheumatoid arthritis and its predictive factors in an unselected adult Chinese population from 2009 to 2018.
    Xie W; Li J; Zhang X; Sun X; Zhang Z
    Int J Rheum Dis; 2019 Sep; 22(9):1670-1678. PubMed ID: 31297977
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Body mass index and response to infliximab in rheumatoid arthritis.
    Ottaviani S; Gardette A; Tubach F; Roy C; Palazzo E; Gill G; Meyer O; Dieudé P
    Clin Exp Rheumatol; 2015; 33(4):478-83. PubMed ID: 25962513
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Significance of sex in achieving sustained remission in the consortium of rheumatology researchers of North America cohort of rheumatoid arthritis patients.
    Jawaheer D; Messing S; Reed G; Ranganath VK; Kremer JM; Louie JS; Khanna D; Greenberg JD; Furst DE
    Arthritis Care Res (Hoboken); 2012 Dec; 64(12):1811-8. PubMed ID: 22730408
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Body mass index distribution in rheumatoid arthritis: a collaborative analysis from three large German rheumatoid arthritis databases.
    Albrecht K; Richter A; Callhoff J; Huscher D; Schett G; Strangfeld A; Zink A
    Arthritis Res Ther; 2016 Jun; 18():149. PubMed ID: 27338263
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.